SGK3 (CISK) may induce tumor angiogenesis (Hypothesis)

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Serum- and glucocorticoid-inducible protein kinase 3 (SGK3), also known as cytokine-independent survival kinase (CISK), is a downstream mediator of phosphatidylinositol 3-kinase (PI3K) oncogenic signaling.
• SGK3 plays critical roles in the oncogenic progression of breast cancer, ovarian cancer, and hepatocellular carcinoma.
• SGK3 regulates cell proliferation, growth, survival, migration, and tumor angiogenesis, functioning parallel to AKT/protein kinase B.

Purpose of the Study:

• To investigate the role of SGK3 in mediating tumor angiogenesis.
• To explore SGK3 as a potential therapeutic target for cancer treatment.

Main Methods:

• The study hypothesizes SGK3's involvement in angiogenesis based on its known downstream targets and parallel function to AKT.
• Further experimental validation is required to elucidate the precise mechanisms.

Main Results:

• The exact association between SGK3 and angiogenesis remains unclear.
• SGK3 target molecules like CXCR4 and GSK3β show potential roles in promoting angiogenesis.

Conclusions:

• SGK3 may play an important role in mediating tumor angiogenesis, similar to AKT.
• Identifying SGK3's role in tumor angiogenesis offers a novel perspective on cancer malignant transformation and presents a potential therapeutic target.